Summary: In previous study of melanocyte-stimulating hormone (MSH) cell development in the proliferating pars intermedia, which is in close apposition to the presumptive pars nervosa, no direct cell-to-cell contact was found between the boundary neurohypophyseal pituicytes (PIC), adenohypophyseal precursor stem cells (PSC) and the related diencephalic mesenchymal cells. Here, we have used immunohistochemistry to examine cytokine expression in the development of the hypophysis during foetal stages II-IV. Light and confocal laser scanning microscopy indicated diffuse expression of both TGFa and EGF in the hypophysis at different foetal. stages. While no findings indicative for tempo rary changes of TGFa and EGF patterns were found in the foetal hypophysis, a temporary increment of EGF molecules was distinct in the diencephalic mesenchyme at stages III and IV. On the other hand, light microscopy intensively immunolocalised EGFR in the adenohypophysis and neurohypophysis at different developmental stages. Immunoreactivity of EGFR in the cytoplasm and nucleus suggested active proliferative events in the PIC and PSC of stages II-IV mouse pituitaries.
We previously detected active cell turnover with programmed cell death in the presumptive adenohypophysis (AP) and neurohypophysis (NP) and their associated cephalic mesenchyme during murine hypophysis development. The transmission electron microscopic (TEM) study suggested that signal transduction between the AP and NP via the extracellular matrix (ECM) might initiate the differentiation of melanocyte-stimulating hormone (MSH) cells in the presumptive pars intermedia at the late mid-foetal stage (Han et al., 1998) .
Epidermal growth factor (EGF) and transforming growth factor alpha (TGFa), which both act via the EGF receptor (EGFR), are multivalent cytokines which control cell proliferation, differentiation and ECM biosynthesis of both the epithelium and mesenchymal cells (Nexo et al., 1980; Todaro et al., 1980; Adamson et al., 1981; Yoneda & Pratt, 1981; Cohen et al., 1982; Adamson, 1983; Cohen, 1986; Abbott et al., 1988) . Recently, the EGFR was also localised to various normal human epithelial tissues, which were categorised according to the intensity and pattern of EGFR expression (Darnjanov et aL, 1996) .
Apoptosis of medial edge epithelial (MEE) cells is presumed to be essential for the fusion of the bilateral secondary palatine shelves (Taniguchi et al., 1995) . A study on murine palatogenesis found that excess exogenous EGF/TGFa caused inhibition of cell death that induces cleft palate due to downregulation of the EGFR (Adams & Warshaw, 1982) . Another study observed that loss of expression of EGF, TGFa and their related receptors may initiate cell death, while epithelia which continuously produce TGFa differentiates stratified squamous keratinising epithelia (Pratt, 1987) . Strong TGFa expression was co-localised with sparse EGF expression in the developing palate of murine foetuses, and strong TGFa and EGFR expression was observed at the degenerative medial MEE remnants during palatogenesis (Abbott et a!. , 1988; Dixon et al., 1991) . Therefore, TGFa appears to play an important role in the degeneration and epithelial-mesenchymal transformation of the MEE region (Ferguson, 1988; Dixon et al., 1991) . Several studies implicated TGFa as the embryonic homo-logue of EGF, since it was usually found in the same locations as EGFR, however a more recent study has demonstrated similar patterns of EGF, TGFa and EGFR expression during morphogenesis of the murine primary palate (Nexo et , 1993) . In the present study, we localised EGF, TGFa and EGFR expression in the developing murine hypophysis by immunohistochernistry to determine their temporo-spatial expression during determination and differentiation of this structure.
Materials and Methods
Foetuses of Sic: ICR SPF mice (SLC, Tokyo, Japan) were removed from the uterus at 9 to 15 days from insemination following the Guidelines for Animal Experimentation at Osaka Dental University. The day the vaginal plug was observed was designated to be the gestational day 0. The development of the foetal hypophysis was divided into four stages (stages I-IV) paralleling other previous studies ( Sasaki & Nishioka, 1988) . In the present study, stage II (gestational days 9-10) foetuses and the head portions of stage III (gestational days [11] [12] and stage IV (gestational days 13-15) samples were trimmed into blocks and fixed by immersion with Carnoy's solution and embedded in paraffine following conventional methods. Serial sagittal 2-5 p.m sections of the middle portion of the head were cut using stainless steel knives mounted on an AS-500 Universal Microtome (Anglia Scientific, Cambridge. UK).
Light Microscopy (LM)
The specimens were deparaffinised and examined mainly with Ultra Vision Mouse Tissue Detectior System Anti-mouse HRP/DAD (Ready-To-Use`, kit (Lab Vison, CA, USA) and anti-mouse anti• EGF monoclonal antibody (Monosan, Uden, The Netherlands) for detection of EGF. Endogenous peroxidase and background non-specific reactions were blocked with Hydrogen Peroxide Block anc Ultra V Block following the manufacturer's in structions, respectively. Reactive Igs were blocked using Rodent Block, and the endogenous biotin was blocked with Avidin D blocking solution and Biotin blocking solution using a Blocking Kit (Vector Lab, CA, USA). The specimens were reacted with the anti-mouse anti-EGF monoclonal antibody (primary antibody; 5 tig/ml, 2h, room temp), biotinylated goat anti-mouse antibody (secondary antibody; 15 min, room temp) and then treated with streptavidin peroxide (15 min, room temp). Subsequently, the DAB substrate-treated specimens were stained with DAB chromogen and counter-stained with methylgreen. The specimens were mounted on slide glasses, embedded in Permount (Fisher Scientific, New Jersey, USA), examined and photographed under an Olympus Vanox-S light microscope (Olympus, Tokyo, Japan).
Expression of the TGFa and EGFR of the developing hypophysis was examined with an anti-rat anti-TGFa polyclonal antibody (primary antibody; Biogenesis, Poole, UK) and anti-EGFR polyclonal antibody (primary antibody; Santa Cruz Biotech, CA, USA) using the ImmunoCruz Staining System (Santa Cruz Biotech, CA, USA). The endogenous peroxidase and non-specific reactions were blocked by peroxide block and serum block, respectively. After blockage, the specimens were further treated with Avidin D blocking solution and Biotin blocking solution, and were then reacted with the antiTGFa and anti-EGFR antibodies. The specimens were reacted with biotinylated secondary antibody and HRP-streptavidin complex, stained by a mixture of DAB Chromogen, peroxidase substrate and substrate buffer, and then were counter-stained by methylgreen and prepared for LM.
Confocal Laser Scanning Microscopy (CLSM)
For localisation of EGF and TGFa molecules using CLSM, some specimens were treated with an anti-EGF antibody (primary antibody; Monasan, Uden, The Netherlands) and an anti-TGFa antibody (primary antibody; Biogenesis, Poole, UK), respectively. The specimens were subsequently treated with biotinylated gout anti-mouse antibody (secondary antibody) for detection of EGF using an UltraVision Mouse Tissue Detection System Anti-mouse HRP/DAD (Ready-To-Use) kit (Lab Vision, CA, USA), as well as with goat anti-rabbit antibody (secondary antibody) for detection of the TGFa using the ImmunoCruz Staining System (Santa Cruz Biotech, CA, USA). Then specimens were reacted with streptavidin, Alexa 488 conjugate (fluorescence wavelength 519 nm; Molecular Probes, Oregon, USA), and the RNA in the tissue was digested by RNase A (Amresco, Ohio, USA). Subsequently, the specimens were counter-stained 
Results
The pattern of expression of TGFa in the developing hypophysis was relatively unchanged at all stages (stages II-IV) by LM. TGFa was diffusely found in the developing AP, NP and in the associated diencephalic mesenchyme, and there were no apparent temporal changes in TGFa expression ( Figs. 1 and 2 ). EGF immunoreactivity in the developing hypophysis was weak but also relatively unchanged at all stages. Weak reactivity was seen on the basement membrane and cells in the NP and AP, with strong expression evident in the associated diencephalic mesenchyme (Figs. 3 and 4) . EGF expression increased with time in the diencephalic mesenchyme (Fig. 4) . EGFR immunoreactivity was seen in the developing hypophysis and surrounding mesenchyme at all stages examined (Figs. 5 and 6 ). Specific EGFR reactivity was seen in the pars distalis at stage IV, and also in the nucleus of actively proliferating NP and AP cells (Figs. 5 and 6) .
CLSM of specimens labelled with streptavidin, Alexa 488 conjugate and PI using the LsAB method showed intense fluorescence (CH1) specific for EGF and TGFa in the presumptive NP and AP at proliferative stage II (Figs. 7a-8) . Similar patterns of expression of TGFa and EGF was seen in the pituitary at stages III-IV (Figs. 8-14) . Consistent with LM, CLSM showed no marked temporal changes in TGFa or EGF expression in the proliferating hypophysis. Histology of the developing hypophysis showed that the NP and AP at stages III-IV were separated with the surrounding diencephalic mesenchyme and capillaries (Figs. 8-10 ). In addition, specific cell-to-cell contacts across a thin immunoreactive layer were seen between the developing NP and pars intermedia at stage IV (Figs. 10 and 13 ).
Discussion
A previous study observed that the diencephalic mesenchymal tissue invaded and thereby cleaved the developing AP into many lobules (Hashimoto et aL, 1998) . Subsequent penetration of vascular elements from the hypophyseal portal system into the foetal pars distalis was suggested to be an important determinant of all secretory cell types in the pituitary (Thompson & Trimble, 1976) . In addition, a three-dimensional histological study of the developing human pituitary showed that AP cells with closer physical contact to the developing NP have increased epithelial characteristics, while cells in the pars distalis which are less proximal to the NP differentiate into endocrine cells earlier (Ikeda et aL, 1988) . In contrast, one study found that ACTH-positive cells have different staining patterns in the foetal and adult pars distalis and pars intermedia, and have specific temporal patterns of expression in different sites of the pituitary (Perry et al., 1985) . However, no selective increase in ACTH-like activity in the anterior pituitary at late gestation was observed using bioassay and radioimmunoassay methods (Fora et al., 1996) . Another study found that isolated ACTH-cells first appeared at the boundaries where pars intermedia cells migrated towards the pituitary anterior lobe (Altukhova et al., 1983). Other studies have stressed that differentiation of MSH cells is evident before vascularisation and innervation, or folliculation of the pars intermedia (Chatterjee, 1975; Perry et aL, 1981; . In a previous TEM study, we observed that the proliferating AP was heavily lobulated, but did not differentiate into endocrine cell types in the mid-foetal stage. In addition, we identified the first appearance of MSH cells in the presumptive pars intermedia (Han et al., 1998) .
A recent study reported that several transcription factors that regulate the determination of specific types and organs were expressed in a ventralto-dorsal gradient at different stages in pituitary organogenesis (Treier et al., 1998 In sits hybridisation showed a decrease in p75 nerve growth factor receptor (NGFR) expression in the Rathke's pouch and pars intermedia during the differentiation of pituitary cell types (Ramaekers et al., 1997) . The 5-100 acidic calcium-binding protein is co-localised with vimentin in melanotropes coinciding with the onset of dopaminergic innervation and morpho-logical changes in glial-like cells of the rat pars intermedia . Furthermore, morphological changes in glial-like cells of the pars intermedia is associated with subsequent changes in protein expression .
The growth and functional differentiation of the adrenal gland is induced by EGF, and inhibited by a glucocorticoid negative feedback mechanism (Coulter et aL, 1996) . In addition, both EGF and fibroblast growth factor-4 (FGF-4) inhibit apoptosis and thereby regulate proliferation and differentiation of dental tissues (Vaahatokari et al., 1996) . In the present study, we localised weak EGF but intense TGFa immunoreactivity in the mouse pituitary at different developmental stages by LM. . In contrast, EGFR was differentially expressed in the pituitary at different stages; intense immunoreactivity was found in the pars distalis at stage IV. EGFR expression in the cytoplasm and nucleus seemed to indicate downregulation by an internalisation mechanism of EGFR and EGF-receptor complexes in the actively proliferating NP and AP cells. The results of the present study are consistent with those of our previous histological study, which indicated that the mid-foetal murine pituitary is at the active proliferation stage (Han et al., 1998) .
TEM of the proliferating AP showed junctional complex in folliculo-stellate cells facing the hypophyseal cleft and zonula adherens-type junctions between the AP cells (Herbert, 1979; Han et al., 1998) . A recent TEM study which showed substance P immunoreactivity in the anterior pituitary suggested that the presence of synaptoid contacts is responsible for cross-talk between the AP glandular cells of the rat (Liu & Ju, 1998) . Observation of intracellular diffusion and freeze-fracture TEM of the cell surface in the pituitary gland have shown a dense cellular network connected by functional gap junction-mediated cell-to-cell communication among agranular folliculo-stellate cells which differentiate into granular and chromophilic cells (Kurono, 1996; Morand et aL, 1996 ; Munari-Silem & Rousset, 1996; Guerineau et aL, 1997; Soji et al., 1997) . However, the development of gap junctions has been reported to be induced by certain paracrine interactions in the pituitary gland (Kurono, 1996; Schwartz et al., 1998 . While LM only showed weak EGF immunoreactivity (Fig. 4) , CLSM clearly identifies EGF expression in a proliferating S3 hypophysis. Fig. 10 . EGF expression in cells of N, A and proliferating PD of an S4 hypophysis by CLSM. Arrowheads indicate that projections from A is very closely associated with N, but they are actually separated by the basement membrane , which shows EGF immunoreactivity. Fig. 11 . CLSM of another S4 specimen. Photo also demonstrates that the A bulged with a large projection, which extends towords the proliferating N. However, the N and A are separated by a thin layer of diencephalic mesenchyme (arrowheads). Fig. 12 . TGFa expression in an S3 specimen viewed under CLSM. TGFa molecules are widely and strongly expressed in the N , A and surrounding tissues. Fig. 13 . Similar to findings in the S3 hypophysis (Fig. 12) , TGFa expression is distinctly localised in the N , A and PD in S4 specimens using CLSM. Arrowheads indicate projections from the presumptive pars intermedia. Fig. 14 . CLSM of TGFa expression in another S4 specimen. An arrowhead also shows the intimate relationship between the N and A.
